upper waypoint

San Francisco Assemblymember Matt Haney to Lead California's New Opioid Committee

Save ArticleSave Article
Failed to save article

Please try again

Assemblyman Matt Haney smiles among a crowd of people.
Assemblymember Matt Haney will lead a bipartisan committee that will look for solutions to the opioid epidemic. (Beth LaBerge/KQED)

San Francisco Assemblymember Matt Haney will lead a bipartisan committee of state lawmakers to investigate solutions to the state’s opioid crisis, which kills thousands of people each year in California.

The 11-member committee named by Assembly Speaker Anthony Rendon includes four Republicans and encompasses representatives from rural and urban districts all around the state.

Haney said they will look for solutions from multiple points of view, including public health and criminal justice.

“If somebody needs a bed to get help, we need to have that available,” he said. “We need effective responses within our criminal justice system. We need support from state and federal [agencies] around the drug supply challenges and drug-dealing issues we're facing.”

In particular, Haney said he wants to push the conversation around overdoses beyond one controversial issue: a recently vetoed bill that would have allowed some cities to operate so-called safe injection sites, where people can use illicit drugs under the supervision of medical personnel.


The bill, which passed without GOP support, was vetoed by Gov. Gavin Newsom, who said he will instead direct state health officials to make their own recommendations for overdose prevention programs.

Haney said there’s no time to waste, and noted that this is a problem plaguing communities around the state, not just urban centers like San Francisco.

related coverage

“I say this as a very strong supporter of safe injection sites: [The veto] can't be used as a reason to not do everything that we possibly can right now,” he said.

“Some of my colleagues have said [safe injection sites are] not going to solve the problem, that we need to stop these drugs, we need to stop the drug dealing, we need to get people into treatment," he added. "And what I said to them about that is, ‘Yes, yes and yes. So we had a small setback around the safe injection sites, but we need the yes, yes and yes to everything else in the meantime.”

Haney should expect the committee’s GOP lawmakers to push some of those other conversations, said Assemblymember Laurie Davies, a Republican who represents southern Orange County. She successfully pushed legislation this year that will make it easier to distribute fentanyl tests, which allow people to detect the presence of the deadly opioid in other drugs.

“There's a lot of other things that we need to work on. But I'm just grateful that eyes are opening and they realize this is a crisis and we can do something to stop it,” she said, adding that one part of the conversation needs to be around prosecuting people who sell deadly fentanyl.

“This isn't just an inner-city problem. It's affecting every parent, it's affecting every race and every color,” Davies said. “We’re losing men, women, children, no matter what the races, what their religion is, what their party affiliation is. This is something that affects every single Californian.”

One of those Californians who has been devastated by the impact of opioids is San Francisco resident Amy Cooper. She lost her son, John, to an overdose in 2014 — and then watched the dentist who had prescribed him the drugs without ever meeting him get acquitted at trial.

Cooper said since John's death, she’s dedicated herself to advocating for solutions and educating people about the fentanyl problem. She said lawmakers need to focus on both education and accountability, including holding both doctors and pharmaceutical companies responsible.

“I can just tell you, 100%, we were uneducated and unaware. We had no idea that this was happening and that it was happening for our son. And then the results are just catastrophic,” she said.

Another aspect of the crisis that some hope to shed light on is the number of young people mistakenly buying drugs — often online — that turn out to be fentanyl. Lee Trope, a pediatric doctor at Santa Clara Valley Medical Center, said many of her patients seem to be experimenting with different substances and wind up becoming addicted to fentanyl or overdosing on it.

“They don't realize what they're buying, oftentimes on apps like Snapchat,” she said. “They think what they're buying — they all call it 'percs' — they think they're buying Percocet, which is a ... less-potent opioid. And it's pure fentanyl.”

Jayme Congdon, a pediatrician and researcher at UC San Francisco, said the new select committee will be raising awareness as it does its work — and she also believes shedding light on the issue is the first step toward change.

Congdon said 250 teens are dying in California each year from opioids. That's seven times the number of pediatric COVID-19 deaths the state has witnessed.

“Because substance use and addiction are stigmatized issues, it's just one of these topics that I think, you know, people think it's not going to affect them or their families until it does,” she said. “We're so pleased to see Assemblymember Haney is taking the lead on this issue so this crisis is hopefully going to start getting the attention that is warranted.”

lower waypoint
next waypoint
San Francisco's 1st Mayoral Debate Is Here. The Stakes Are HighAs California's Transitional Kindergarten Enrollment Grows, Parents Must Make Big ChoicesFor High Schoolers in the South Bay, Silicon Valley LoomsIn Oakland's Fruitvale, a Model of Urban Development That Serves Working ClassSan Francisco's New License Plate Readers Are Leading to Arrests — and Concerns About PrivacyNewsom Proposes Cuts to Medi-Cal Amid Budget DeficitSF Mayor Candidates Speak to Their Bases and No One Else at 1st DebateTaco Bell, KFC Workers in San José Walk Out Over Hot, Dangerous ConditionsCalifornia Forever's Bid to Build a New City Qualifies for November BallotCOVID Keeps Rising in Bay Area Wastewater. What to Know, From New Variants to Symptoms